威尔药业
(603351)
| 流通市值：36.96亿 | | | 总市值：36.96亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,081,742,117.54 | 739,595,699.21 | 356,303,724.13 | 1,335,037,035.4 |
| 营业收入 | 1,081,742,117.54 | 739,595,699.21 | 356,303,724.13 | 1,335,037,035.4 |
| 二、营业总成本 | 945,483,746.99 | 650,678,864.07 | 313,328,245.76 | 1,170,622,101.96 |
| 营业成本 | 779,884,213.53 | 535,364,295.56 | 258,375,425.47 | 955,039,689.35 |
| 税金及附加 | 6,828,606.9 | 4,347,538.99 | 2,337,521.51 | 8,655,170.58 |
| 销售费用 | 12,499,136.25 | 7,853,204.83 | 3,341,443.74 | 16,865,139.75 |
| 管理费用 | 75,646,150.94 | 53,933,283.93 | 24,384,580.6 | 97,034,374.5 |
| 研发费用 | 60,052,041.71 | 40,660,520.02 | 19,093,875.62 | 81,530,712.66 |
| 财务费用 | 10,573,597.66 | 8,520,020.74 | 5,795,398.82 | 11,497,015.12 |
| 其中:利息费用 | 8,383,651.74 | 6,405,104.77 | 3,848,448.22 | 10,681,231.9 |
| 其中:利息收入 | 581,279.35 | 473,973.84 | 113,836.77 | 504,607.31 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,913,685.43 | -1,823,673.41 | - | 3,413,109.64 |
| 加:投资收益 | -36,570.48 | -36,570.48 | - | 24,989.15 |
| 资产处置收益 | - | - | - | 16,250.03 |
| 资产减值损失(新) | -1,987,279.24 | -1,939,822.41 | - | -6,031,196.28 |
| 信用减值损失(新) | 63,905.24 | -817,352.48 | -880,076.57 | -362,660.43 |
| 其他收益 | 6,048,363.7 | 3,530,061.81 | 1,830,676.44 | 11,615,167.25 |
| 四、营业利润 | 138,433,104.34 | 87,829,478.17 | 43,926,078.24 | 173,090,592.8 |
| 加:营业外收入 | 2,207,145.06 | 2,194,198.94 | - | - |
| 减:营业外支出 | 105,502.59 | 69,345.23 | 3,681.92 | 445,699.85 |
| 五、利润总额 | 140,534,746.81 | 89,954,331.88 | 43,922,396.32 | 172,644,892.95 |
| 减:所得税费用 | 22,248,224.89 | 14,429,454.72 | 7,074,399 | 23,657,821.65 |
| 六、净利润 | 118,286,521.92 | 75,524,877.16 | 36,847,997.32 | 148,987,071.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 118,286,521.92 | 75,524,877.16 | 36,847,997.32 | 148,987,071.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 120,042,004.82 | 76,782,890.16 | 37,634,039.87 | 150,968,971.49 |
| 少数股东损益 | -1,755,482.9 | -1,258,013 | -786,042.55 | -1,981,900.19 |
| 扣除非经常损益后的净利润 | 117,617,656.76 | 75,995,110.05 | 37,630,489.98 | 145,849,212.35 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.89 | 0.57 | 0.28 | 1.11 |
| (二)稀释每股收益 | 0.89 | 0.57 | 0.28 | 1.11 |
| 九、综合收益总额 | 118,286,521.92 | 75,524,877.16 | 36,847,997.32 | 148,987,071.3 |
| 归属于母公司股东的综合收益总额 | 120,042,004.82 | 76,782,890.16 | 37,634,039.87 | 150,968,971.49 |
| 归属于少数股东的综合收益总额 | -1,755,482.9 | -1,258,013 | -786,042.55 | -1,981,900.19 |
| 公告日期 | 2026-10-29 | 2026-08-22 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |